RACGP Interprofessional approaches in the treatment of opioid dependence: Spotlight on Pharmacist administration of depot buprenorphine - Webinar

Details

This webinar explores ways GPs and Pharmacists can work together to support patients with opioid dependence by providing greater access to the full range of treatment options, including depot buprenorphine. Community pharmacist administration has been explored in a pilot project led by the University of Sydney and the Ministry of Health. 

GP and addiction medicine specialist, Dr Hester Wilson discusses the place of depot buprenorphine as a treatment option, and how GPs and community pharmacists can benefit from working together to support patient care.
 
Pharmacist Joel Hillman from Sydney LHD and the University of Sydney will share some early findings from the NSW Depot Buprenorphine in Pharmacy Pilot. He will discuss the approach to support pharmacist administration, minimum requirements, training package and resources.

Learning outcomes

1. Compare and contrast depot buprenorphine as a treatment option for opioid dependence and outline steps to commence or transfer a patient to depot buprenorphine.
2. Identify patients prescribed depot buprenorphine who are suitable for community pharmacist administration.
3. Implement referral and communication models, where appropriate, between GPs, Drug and Alcohol specialist services and pharmacists to support quality patient outcomes.
4. Apply a structured approach to review and assess patients who have been prescribed depot buprenorphine as opioid treatment.

Time: 7:30pm -8:30pm

RACGP CPD: 1 hour EA

Audience: Free for GPs and non-GPs